---
title: "Liance Technology: Net profit of 82.505 million yuan in 2024, a year-on-year decrease of 8.99%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237690906.md"
description: "Liance Technology announced that the operating revenue for 2024 is 493 million yuan, a year-on-year decrease of 0.42%. The net profit attributable to shareholders of the listed company is 82.505 million yuan, a year-on-year decrease of 8.99%. It plans to distribute a cash dividend of 1.81 yuan for every 10 shares to all shareholders. The total cash dividend for the company in 2024 is 25.5014 million yuan, accounting for 30.91% of the net profit attributable to ordinary shareholders of the listed company in the consolidated financial statements"
datetime: "2025-04-27T08:10:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237690906.md)
  - [en](https://longbridge.com/en/news/237690906.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237690906.md)
generator: "portal-rs"
---

# Liance Technology: Net profit of 82.505 million yuan in 2024, a year-on-year decrease of 8.99%

Liance Technology announced that the operating revenue for 2024 is 493 million yuan, a year-on-year decrease of 0.42%. The net profit attributable to shareholders of the listed company is 82.505 million yuan, a year-on-year decrease of 8.99%. It plans to distribute a cash dividend of 1.81 yuan for every 10 shares to all shareholders. The total cash dividend for the year 2024 is 25.5014 million yuan, accounting for 30.91% of the net profit attributable to ordinary shareholders of the listed company in the consolidated financial statements

### Related Stocks

- [688113.CN](https://longbridge.com/en/quote/688113.CN.md)

## Related News & Research

- [Sinotrans schedules online briefing on 2026 interim results](https://longbridge.com/en/news/296213993.md)
- [CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline](https://longbridge.com/en/news/296024108.md)
- [VirExit unit FleetPath signs LOI with Seven and Two as first controlled beta carrier partner](https://longbridge.com/en/news/296228769.md)
- [Terra Balcanica affiliate Terra North starts airborne radiometric, magnetic survey at Saskatchewan uranium project](https://longbridge.com/en/news/296352202.md)
- [BioNxt completes IMPD, moves toward first human bioequivalence trial for sublingual cladribine film in MS](https://longbridge.com/en/news/296314929.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**